View more PowerPoint from optimpharma
Thursday 1 March 2012
Monday 27 February 2012
Lantheus ties up with Double-Crane for distribution & supply of Definity in China
Lantheus Medical Imaging, Inc., a global leader in developing,
manufacturing and distributing innovative diagnostic imaging agents,
entered into a strategic distribution arrangement with Beijing
Double-Crane Pharmaceutical Co., LTD. (Double-Crane), a leading
pharmaceutical company, for Definity Vial for (Perflutren Lipid
Microsphere) Injectable Suspension in the People’s Republic of China,
including Hong Kong S.A.R. and Macau S.A.R.
USPTO grants patent titled 'method of therapeutic administration of DHE' to MAP Pharma
The United States Patent and Trademark Office (USPTO) issued to the MAP
Pharmaceuticals' US Patent No. 8,119,639, titled "Method of Therapeutic
Administration of DHE to Enable Rapid Relief of Migraine while
Minimizing Side Effect Profile."
Vasan Eye Care Hospital performs first permanent eye colour change surgery in India
Vasan Eye Care Hospital, Trichy, the world's largest eye care provider
has successfully performed India’s first permanent eye colour change
surgery on a young lady of 25 years from New Zealand who wanted her
brown eyes changed to her favourite olive green colour.
This surgery was performed by Dr Shibu Varkey and his team at the hospital. With the use of new and high tech surgical procedure the surgeons at Vasan Eye Care implanted artificial Iris in the young lady's eyes according to her colour preference.
This surgery was performed by Dr Shibu Varkey and his team at the hospital. With the use of new and high tech surgical procedure the surgeons at Vasan Eye Care implanted artificial Iris in the young lady's eyes according to her colour preference.
Elder Pharma & Combe launch Vagisil range of feminine personal hygiene products in India
Elder Pharmaceuticals Ltd, one of the fastest growing pharmaceutical
companies in the country, in association with New York based Combe Inc.,
a global brand leader in feminine care, has launched the Vagisil range
of feminine personal hygiene products today in India.
Vagisil has been a world leader in feminine care for over four decades and is the most trusted and well accepted brand in over 40 countries across the globe. Combe Inc., and Elder Pharma are introducing three key solutions to help Indian women with their feminine needs: Vagisil Anti-Itch Creme, Vagisil Intimate Feminine Wash and Vagisil Intimate Feminine Lubricant.
Vagisil has been a world leader in feminine care for over four decades and is the most trusted and well accepted brand in over 40 countries across the globe. Combe Inc., and Elder Pharma are introducing three key solutions to help Indian women with their feminine needs: Vagisil Anti-Itch Creme, Vagisil Intimate Feminine Wash and Vagisil Intimate Feminine Lubricant.
Glenmark recalls select lot of oral contraceptive in US
Glenmark Pharmaceuticals
today said it has issued a voluntary nationwide recall in the US for
seven lots of its oral contraceptive Norgestimate and Ethinyl Estradiol
tablets due to a packaging error.
The recall is issued by the company's US arm Glenmark Generics Inc for tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg.
"The recall is being implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch," it added.
The recall is issued by the company's US arm Glenmark Generics Inc for tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg.
"The recall is being implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch," it added.
Saturday 25 February 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel
Company: BioSante Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc.
Date of Approval: February 14, 2012
Treatment for: Hypogonadism -- Male
Bio-T-Gel (testosterone) is a once-daily transdermal testosterone gel for the treatment of male hypogonadism or low
testosterone levels. Date of Approval: February 14, 2012
Treatment for: Hypogonadism -- Male
FDA Approves Korlym for Patients with Endogenous Cushing's Syndrome
Company: Corcept Therapeutics
Date of Approval: February 17, 2012
Treatment for: Cushing's Syndrome
Date of Approval: February 17, 2012
Treatment for: Cushing's Syndrome
Korlym
(mifepristone) is a cortisol receptor blocker indicated to control
hyperglycemia secondary to hypercortisolism in adult patients with
endogenous Cushing's syndrome who have type 2 diabetes mellitus or
glucose intolerance.
Subscribe to:
Posts (Atom)